Brief telehealth psychological support during pre-surgery (neoadjuvant) treatment for localized pancreatic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center intervention enrolls adults with newly diagnosed localized pancreatic ductal adenocarcinoma who plan to start neoadjuvant therapy. Participants receive one 40-minute telehealth session per week with a psychologist for four weeks, alongside standard referrals for nutritional and physical therapy. The study will measure feasibility and acceptability and collect preliminary data on quality of life and stress/anxiety outcomes. Patients with metastatic disease, those unlikely to undergo surgery, or who have already received two or more chemotherapy cycles are excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults ≥ 18 years of age
* Patient:

  * Newly diagnosed patients with localized pancreatic ductal adenocarcinoma (PDAC) presenting to Ohio State University Wexner Medical Center-Comprehensive Cancer Center (OSUMC-CCC)
  * Plans to initiate neoadjuvant therapy prior to surgical resection
  * Neoadjuvant therapy (NT) and/or surgery may occur at another facility

Exclusion Criteria:

* Prisoners
* Persons unable to provide consent
* Patients unlikely to undergo surgical resection following NT based on anatomical or performance status considerations
* Confirmed or presumed metastatic disease
* Already received ≥ 2 cycles of chemotherapy

Where it's running

• Ohio State University Comprehensive Cancer Center
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Jordan M Cloyd, MD — Ohio State University Comprehensive Cancer Center
• Study coordinator: The Ohio State University Comprehensive Cancer Center
• Email: OSUCCCClinicaltrials@osumc.edu
• Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Imaging cancer-associated fibroblasts in localized pancreatic cancer

  This study is testing a special type of scan to see if it can help find certain cells in patients with localized pancreatic cancer and predict how well they will do after surgery.

  Recruiting Phase 2 Mayo Clinic · Rochester, Minnesota · NCT05518903

• A tailored web program to boost exercise and healthy eating for pancreatic cancer patients before surgery

  This trial tests a personalized web portal called COMPASS to help adults with stage I–III pancreatic cancer who are receiving neoadjuvant chemotherapy to improve exercise and dietary habits.

  Recruiting OHSU Knight Cancer Institute · Portland, Oregon · NCT07651358

• Exploring how diet and gut bacteria affect chemotherapy response in pancreatic cancer

  This study is testing how diet and gut bacteria affect how well people with pancreatic cancer respond to chemotherapy.

  Recruiting Emory University · Atlanta, Georgia · NCT06595160

• Neoadjuvant chemotherapy for resectable pancreatic cancer

  This study is testing a combination of three chemotherapy drugs to see if it helps people with resectable pancreatic cancer get better before surgery.

  Recruiting Phase 2 Georgetown University · Washington D.C., District of Columbia and 1 other locations · NCT06423326

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.